Dublin, Aug. 17, 2017 -- The "North America Drug Delivery Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.
The North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024, at a CAGR of 6.4% during the forecast period of 2017 to 2024.
Scope of the Report
- North America Drug Delivery Market is segmented based on product type, end-user, distribution channel, and geography.
- On the basis of route of administration the drug delivery market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal.
- Based on distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.
- On the basis of end users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.
- The North America drug delivery market is segmented into 3 major countries such as U.S., Canada, and Mexico.
Key Topics Covered:
1. Introduction
1.1. Overview of North America Drug Delivery Devices Market
1.2. Currency and Pricing
1.3. Limitation
1.4. Markets Covered
2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered for the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions
3. Market Overview
3.1. Drivers
3.1.1. Rising Prevalence of Chronic Disease Such as Diabetes
3.1.2. Growth in the Development of Biologics
3.1.3. Technological Development
3.2. Restraints
3.2.1. Risk of Needle-Stick Injuries and Side Effects
3.3. Opportunities
3.3.1. Rising Acceptance of Self Administering Drugs
3.3.2. Rising Demand for Biosimilars and Generic Drugs
3.3.3. Trend of Merger and Acquisitions, and Collaborations
3.3.4. Focus on Patient Needs
3.3.5. Developing and New Emerging Revenue Pockets
3.4. Threats
3.4.1. Product Recalls
3.4.2. Stringent Regulatory and High Pricing
3.4.3. Patent Expiry and Patent Cliff
4. Executive Summary
5. Premium Insights
6. North America Drug Delivery Devices Market, by Product Type
6.1. Overview
6.2. North America Oral Drug Delivery Market, by Product Type
6.3. North America Solid Oral Drug Delivery Market,
By Product Type
6.4. North America Liquid Oral Drug Delivery Market,
By Product Type
6.5. North America Semi-Solid Oral Drug Delivery Market,
By Product Type
6.6. North America Pulmonary Drug Delivery Market,
By Product Type
6.7. North America Nebulizers Market, by Product Type
6.8. North America Injectable Drug Delivery Market,
By Product Type
6.9. North America Injectable Drug Delivery Devices,
By Product Type
6.9.1. North America Conventional Injectable Drug Delivery Devices Market
6.9.2. North America Self-Injection Drug Delivery Devices Market, by Product Type
6.10. North America Injectable Drug Delivery Formulations Market, by Product Type
6.11. North America Ophthalmic Drug Delivery Market,
By Product Type
6.12. North America Ophthalmic Drug Delivery Formulations Market,By Form
6.13. Ophthalmic Drug Delivery Devices, by Product Type
6.14. North America Nasal Drug Delivery Market, by Product Type
6.15. North America Topical Drug Delivery Market, by Product Type
6.16. North America Transdermal Drug Delivery Devices Market, by Product Type
6.17. North America Topical Drug Delivery Formulations Market, by Product Type
6.17.1. North America Semi Solid Topical Drug Delivery Formulations Market, by Type
6.17.2. North America Liquid Topical Drug Delivery Formulations Market, by Type
6.17.3. North America Solid Topical Drug Delivery Formulations Market, by Type
6.18. North America Implantable Drug Delivery Market,
By Product Type
6.19. North America Transmucosal Drug Delivery Market,
By Product Type
6.20. North America Oral Transmucosal Drug Delivery Market, by Product Type
6.21. North America Oral Transmucosal Drug Delivery Market, by Product Type
7. North America Drug Delivery Devices Market, by End User
7.1. Overview
8. North America Drug Delivery Devices Market, by Distribution Channel
8.1. Overview
9. Drug Delivery Market, by Geography
9.1. North America Drug Delivery Devices Market
9.2. U.S. Drug Delivery Devices Market
9.3. Canada Drug Delivery Devices Market
9.4. Mexico Drug Delivery Devices Market
10. North America Drug Delivery Devices Market, Company Share
10.1. Company Share Analysis: North America
11. Company Profiles
- F. Hoffmann-La Roche AG
- Pfizer Inc.
- GlaxoSmithKline plc.
- Merck & Co.
- Sanofi
- Antares Pharma
- 3M
- Becton Dickinson and Company
- Nemera
- Cima Labs Inc.
- Dali Medical Devices
- Alkermes
- Foamis
- Ypsomed
- Skyepharma AG
- Valeant Pharmaceuticals DSM Biomedical
- Catalent Inc.
For more information about this report visit https://www.researchandmarkets.com/research/n29rln/north_america
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery


Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tesla Launches New Model Y Variant in the US Starting at $41,990
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 



